Functionalized congeners of 1,3-dipropyl-8-phenylxanthine: potent antagonists for adenosine receptors that modulate membrane adenylate cyclase in pheochromocytoma cells, platelets and fat cells
about
Non-xanthine heterocycles: activity as antagonists of A1- and A2-adenosine receptorsBinary drugs: conjugates of purines and a peptide that bind to both adenosine and substance P receptorsApparent affinity of some 8-phenyl-substituted xanthines at adenosine receptors in guinea-pig aorta and atriaXanthines as adenosine receptor antagonists.Nomenclature and classification of purinoceptors.NCI-H295R, a human adrenal cortex-derived cell line, expresses purinergic receptors linked to Ca²⁺-mobilization/influx and cortisol secretionXAC, a functionalized congener of 1,3-dialkylxanthine, antagonizes A1 adenosine receptor-mediated inhibition of renin secretion in vitro.A [3H]amine congener of 1,3-dipropyl-8-phenylxanthine. A new radioligand for A2 adenosine receptors of human platelets.[3H]xanthine amine congener of 1,3-dipropyl-8-phenylxanthine: an antagonist radioligand for adenosine receptors.1,3,8- and 1,3,7-substituted xanthines: relative potency as adenosine receptor antagonists at the frog neuromuscular junctionThe inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines.A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.Molecular probes for extracellular adenosine receptors.Riboflavin: Inhibitory Effects on Receptors, G-Proteins, and Adenylate Cyclase.Xanthine functionalized congeners as potent ligands at A2-adenosine receptors.8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo.Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors.8-Substituted xanthines as antagonists at A1- and A2-adenosine receptors.A new high affinity, iodinated adenosine receptor antagonist as a radioligand/photoaffinity crosslinking probe.Activation and Desensitization of Rat A3-Adenosine Receptors by Selective Adenosine Derivatives and Xanthine-7-Ribosides.A1- and A2-selective adenosine antagonists: in vivo characterization of cardiovascular effectsFurther characterization of the renovascular effects of N6-cyclohexyladenosine in the isolated perfused rat kidney.Improvement of cold tolerance by selective A1 adenosine receptor antagonists in rats.
P2860
Q24599034-34D69C41-9265-49DD-9E30-B8C2538F6244Q28338174-2CA5C374-523E-4293-AF61-963911D52D82Q28361938-25DB5AE1-D12E-4EE2-B09E-A03EFA9D08D9Q34139398-AE652B7F-0112-482A-9E8F-97FAB3EB9384Q34324355-44632971-74EB-4365-A573-75A146AC25F3Q34948476-33D1F881-6E24-4349-8306-0FBBA4297003Q35024951-5E2B1952-C26A-4514-BA83-E0C7C4A84EA3Q35153360-D569EA81-AD45-4A50-A8EF-A2C248969AE4Q35609958-4113D691-5342-4926-B914-2A78AA0F31FAQ35756157-4D5CCE7A-73AE-4EA7-81DE-C0F9B9371D7AQ35888292-115042E0-D5FC-45A9-A6E7-DDBD4958A847Q35911207-61885298-4C5A-4D8B-BC9B-A0F21CF98200Q36072729-73FA6DD0-3401-4543-B1FC-D8050DCA33AEQ36076482-8ED8036C-8CEC-49FF-B709-37BB974E38F1Q36208390-EE7A433E-6963-4707-8EE5-E6039DEC3C96Q36308893-A8234CDB-72BC-4AA5-AA8E-55D4289FD122Q36311732-E9948AF1-ABF0-4869-BB7C-26C950D6043EQ36311755-595B4F20-78C5-4360-ADCE-5FAD9BB2D948Q36340934-8848192E-E68F-4CD3-BBF0-B6F2D5FA7B03Q36661011-1401AC24-0F3B-4E1D-9758-B9784E0A5872Q41169053-8A1255E2-6D92-43E3-A744-5C646726A110Q41264510-5AAFC0DC-067C-4E67-A0FD-0907E4C2A5B7Q42393484-B1F52D54-BC44-48E6-959C-CFD93BCB868D
P2860
Functionalized congeners of 1,3-dipropyl-8-phenylxanthine: potent antagonists for adenosine receptors that modulate membrane adenylate cyclase in pheochromocytoma cells, platelets and fat cells
description
1986 nî lūn-bûn
@nan
1986 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի մարտին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Functionalized congeners of 1, ...... cells, platelets and fat cells
@ast
Functionalized congeners of 1, ...... cells, platelets and fat cells
@en
Functionalized congeners of 1, ...... cells, platelets and fat cells
@nl
type
label
Functionalized congeners of 1, ...... cells, platelets and fat cells
@ast
Functionalized congeners of 1, ...... cells, platelets and fat cells
@en
Functionalized congeners of 1, ...... cells, platelets and fat cells
@nl
prefLabel
Functionalized congeners of 1, ...... cells, platelets and fat cells
@ast
Functionalized congeners of 1, ...... cells, platelets and fat cells
@en
Functionalized congeners of 1, ...... cells, platelets and fat cells
@nl
P2093
P2860
P1433
P1476
Functionalized congeners of 1, ...... cells, platelets and fat cells
@en
P2093
P2860
P304
P356
10.1016/0024-3205(86)90596-5
P407
P577
1986-03-03T00:00:00Z